Marinelli JP, Anzalone CL, Prummer CM, et al
Each insertion introduces a small contamination risk
Some individuals report changes within days or weeks, while others may require a longer period of treatment
This shift reflects a broader recognition that health interventions should be tailored to individual needs, genetic predispositions, and lifestyle factors
Rather than being driven by cardiomyocyte loss and impaired systolic function, HFpEF develops in the context of systemic comorbiditiessuch as hypertension, T2DM, coronary artery disease (CAD), chronic kidney disease (CKD), anemia, AF, obesity, and pulmonary diseasethat contribute to a chronic low-grade inflammatory state